Vir Biotechnology, Inc.
VIR
$4.62
$0.2355.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.91% | -7.08% | 15.14% | 11.21% | -84.39% |
| Total Depreciation and Amortization | -35.18% | -29.57% | -25.15% | -4.57% | 27.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.32% | -20.10% | 18.91% | 66.13% | 201.19% |
| Change in Net Operating Assets | 101.02% | 106.26% | 72.64% | 30.25% | 12.60% |
| Cash from Operations | -1.43% | 45.56% | 42.69% | 26.60% | -24.58% |
| Capital Expenditure | -14.68% | 57.43% | 66.16% | 80.29% | 83.74% |
| Sale of Property, Plant, and Equipment | 205.48% | 485.37% | -- | 4,268.18% | 8,390.91% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 439.78% | 442.00% | 170.30% | 74.12% | 118.92% |
| Cash from Investing | 480.39% | 529.43% | 203.33% | 118.24% | 115.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.99% | 7,000.00% | -- | 157.76% | 149.63% |
| Issuance of Common Stock | -19.04% | -13.17% | -41.38% | -37.31% | -45.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.53% | 21.71% | -5.57% | -- | -- |
| Cash from Financing | -22.04% | -8.59% | -41.34% | -38.48% | -46.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.05% | 128.32% | 109.46% | 59.34% | 55.98% |